Physician profile
Robin Harding
NPI 1881823136
$859.84
in general payments reported to CMS, 2019-2025
16 companies · $57.13 in 2025
The $57.13 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $258 · 2021: $219 · 2022: $121 · 2023: $45.22 · 2024: $48.01 · 2025: $57.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $118 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.09 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.06 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $99.81 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $95.17 | 2019-2020 | |
| Welch Allyn | $91.77 | 2021 | |
| Baxter Healthcare | $85.65 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.13 | 2020 | |
| Pfizer INC. | $62.99 | 2019-2020 | |
| Mylan Specialty L.P. | $44.23 | 2019-2020 | |
| Lilly USA, LLC | $30.43 | 2020-2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $23.56 | 2021 | |
| Nevro Corp. | $20.38 | 2023 | Senza |
| Sunovion Pharmaceuticals INC. | $17.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.37 | 2020 | |
| Allergan, INC. | $14.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $9.93 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Harding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.